1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis | Phase 1 / Phase 2 | Terminated | National Human Genome Research Institute (NHGRI) | 3 | 2007-04-01 | 2013-08-02 |
Albinism (1) · Albinism, Oculocutaneous (1) · Hermanski-Pudlak Syndrome (1) · Lung Diseases (1) · Metabolic Diseases (1) · Platelet Storage Pool Deficiency (1) · Pulmonary Fibrosis (1)
Amino Acid Metabolism, Inborn Errors (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Platelet Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Fibrosis (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Lung Diseases, Interstitial (1) · Metabolism, Inborn Errors (1)
Acetylcysteine (1) · Erythromycin (1) · Losartan (1) · Pravastatin (1) · zileuton (1)
National Human Genome Research Institute (NHGRI) (1)
United States (1)